June 18, 2018
FDA issues Safety Alert for compounded drugs containing triamcinolone, moxifloxacin
Editor's Note
The Food & Drug Administration (FDA) on June 14 issued a Safety Alert for compounded drugs containing triamcinolone and moxifloxacin by Guardian Pharmacy Services (Dallas, Texas).
At least 43 patients have reported adverse events after receiving eye injections of the compounded triamcinolone and moxifloxacin drug during cataract surgery.
The Guardian Pharmacy Services in Dallas is not affiliated with the national long-term care Guardian Pharmacy Services, LLC headquartered in Atlanta.
Free Daily News
- Study: COVID-19's impact on oncological surgery offers lessons for future crises
- Study links pandemic stress to persistent increases in nursing-sensitive quality indicators
- Save the date for the 2025 OR Business Management Conference
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement